Enjoy this discussion with Drs. Daniel Friedman, Infectious Disease Specialist, and Taylor Heald-Sargent, Pediatric Infectious Disease expert, as they explore one of the most complex aspects of transplant medicine: managing infection risk in immunocompromised patients. Drawing on their clinical and research experience, the conversation takes a deep dive into how infections impact transplant recipients across the continuum of care. From pre-transplant screening and prevention strategies to post-transplant management, both physicians emphasize the importance of proactive planning and individualized care for patients with weakened immune systems. A central theme is the evolving nature of infectious disease in transplant populations. The physicians discuss how globalization, shifting environmental patterns, and advances in diagnostics are changing the way clinicians think about pathogens. Traditional geographic boundaries of infections are becoming less predictable, requiring clinicians to think more broadly and remain adaptable in their diagnostic approach. The episode also highlights the complexity of treating viral and fungal infections in these patients. Dr. Heald-Sargent focuses on viral infections such as cytomegalovirus, while Dr. Friedman shares insights into invasive fungal infections and their unpredictable nature. Together, they illustrate how collaboration across specialties is essential to delivering effective care. Hosted by Kevin Foth of Eurofins Viracor. Episode Links: Taylor Heald-Sargent, MD | LinkedIn Lurie Children's Hospital Daniel Z. Friedman University of Chicago | Bio Be a Guest on our Show! We’re always looking to speak with the transplant community. To be considered, please email ---> Amplify your influence! 📧 [email protected] Social Media: LinkedIn | X-Twitter | Facebook | Threads | YouTube | Bluesky Disclaimer: The opinions expressed by the host and guests are solely their own and do not necessarily represent the views of the company. This content is provided for informational purposes only and is not intended to be, nor should it be interpreted as, medical advice, diagnosis, or treatment. Please consult a qualified healthcare professional for medical guidance specific to your situation. For more information visit: Eurofins-Viracor.com or call (800)305-5198 Copyright © 2026 Eurofins Viracor, LLC. All Rights Reserved. 🎧 Home of Transplant Radio™

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related